Every 10-Q that International Flavors & Fragrances Inc. (IFF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow IFF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IFF filings page.
International Flavors & Fragrances Inc. reported second‑quarter 2026 net sales from continuing operations of $1,954 million, slightly up from $1,919 million a year earlier. Operating profit from continuing operations was $158 million versus $142 million, while income from continuing operations before taxes declined to $64 million from $438 million, reflecting the absence of a prior‑year $488 million debt extinguishment gain and higher regulatory and other special costs.
Net income attributable to IFF shareholders was $50 million for the quarter, or $0.20 diluted EPS, compared with $599 million or $2.33 a year earlier. For the first six months of 2026, net income attributable to shareholders was $219 million, versus a loss of $419 million in the prior‑year period, helped by discontinued operations moving from a $1,036 million loss to a $33 million profit.
The company agreed to sell its Food Ingredients business for estimated proceeds of $3.832 billion, retaining a 10% equity interest; together with the earlier Soy Crush, Concentrates & Lecithin divestiture, this represents a strategic shift and is reported as discontinued operations. A separate sale of the CitraSource business led to a $27 million loss on assets held for sale. Operating cash flow for the first half of 2026 increased to $679 million, while total debt was $5,699 million at June 30, 2026, including $50 million of commercial paper.
International Flavors & Fragrances Inc. (IFF) reported first-quarter 2026 net income attributable to shareholders of $169 million, or $0.66 per share, compared with a net loss of $1,018 million a year earlier that included a large goodwill impairment.
Net sales were $2.741 billion, down 4% on a reported basis, but up 3% on a comparable currency-neutral basis as divestitures reduced sales by about $289 million. Gross margin improved to 37.1%, helped by productivity gains and mix, while selling and administrative expenses fell.
Segment performance was broad-based: Taste, Food Ingredients, Health & Biosciences, and Scent all grew sales on a comparable currency-neutral basis, and consolidated Adjusted Operating EBITDA margin edged up to 20.7%. Operating cash flow strengthened to $257 million, supporting $165 million of capital expenditures, $35 million of share repurchases, and $102 million in dividends.
The company continued portfolio reshaping, completing the divestiture of its Soy Crush, Concentrates & Lecithin business and previously exiting Pharma Solutions. It also recorded provisions and ongoing costs related to U.S. fragrance class action settlements and global competition investigations, while noting certain investigations have been closed or are covered by insurance in specific cases.
International Flavors & Fragrances (IFF) reported Q3 2025 results showing softer sales but positive net income. Net sales were $2,694 million versus $2,925 million a year ago, and net income attributable to shareholders was $40 million (diluted EPS $0.16) versus $58 million ($0.23). Adjusted Operating EBITDA was $519 million versus $568 million.
Year‑to‑date, IFF posted a net loss of $392 million driven by a $1,153 million goodwill impairment and a $108 million loss on assets held for sale, partially offset by a $488 million gain on extinguishment of debt. Cash from operations reached $532 million, aided by divestiture activity: the Pharma Solutions sale closed for $2,564 million cash (fair value consideration $2,651 million including a $100 million earnout estimate), the Nitrocellulose sale brought $161 million, and a Tobacco Flavoring business sale yielded $20 million.
The balance sheet strengthened: cash was $621 million and long‑term debt fell to $4,741 million from $7,564 million. IFF recorded a $108 million impairment for the Soy Crush, Concentrates & Lecithin business now held for sale, with closing expected by the second quarter of 2026. The Board also authorized a $500 million share repurchase program.